US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

  2    4  5  6  7  8  9  10  
Antibodies in Oncology: Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 107 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 264 drug targets that are included ...  |  read more...
$5,622.50
Analytical Tool - Cancer Therapeutic Antibodies
3/25/2014 | published by: BioSeeker Group AB
... of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product ...  |  read more...
$14,810.00
Antibodies in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... for the second wave in the lucrative field of therapeutic antibodies. There are today 313 companies plus partners developing 671 antibody drugs in 1619 developmental projects in cancer. In addition, there are 8 suspended drugs ...  |  read more...
$5,622.50
Biologicals in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... developing 1620 biological drugs in 3685 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 920 drugs. Biologicals In ...  |  read more...
$9,372.50
MicroRNAs in Cancer Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... with minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us ...  |  read more...
$5,622.50
Cancer Stem Cells Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
$5,622.50
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... molecules or protein-based therapies. There are today 56 companies plus partners developing 96 RNA (miRNA, RNAi & siRNA) drugs in 129 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the ...  |  read more...
$3,747.50
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
$1,872.50
Proteins in Oncology: Drug Pathway Analyzer 2014
3/25/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 79 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 160 drug targets that are included ...  |  read more...
$5,622.50
Analytical Tool - Cancer Immunotherapy
3/25/2014 | published by: BioSeeker Group AB
... is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays ...  |  read more...
$20,437.50
China National Biotec Group - Strategic SWOT Analysis Review
3/24/2014 | published by: GlobalData
... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ...  |  read more...
$125.00
ViaCord, LLC - Strategic SWOT Analysis Review
3/24/2014 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
$125.00
Ablynx NV (ABLX) - Financial and Strategic SWOT Analysis Review
3/24/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
$125.00
Alcohol and Starch/Sugar Enzyme Market by Type (Carbohydrase, Protease, and Lipase), by Application (Industrial, Specialty) & Geography - Global Trends & Forecasts to 2018
3/24/2014 | published by: MarketsandMarkets
... incorporate the production of food and beverages, biofuels, cleaning agents, and others. Due to their versatile applications, alcohol enzymes are in great demand to suffice the tremendous requirement for industrial products from consumers.The alcohol and ...  |  read more...
$4,650.00
CLC bio - Strategic SWOT Analysis Review
3/24/2014 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
$125.00
3SBio Inc. (SSRX) - Financial and Strategic SWOT Analysis Review
3/24/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
$125.00
Novartis South Africa (Pty) Ltd in Consumer Health (South Africa)
3/21/2014 | published by: Euromonitor International
... continually look for merger and acquisition opportunities internationally to further extend its reach across geographies. Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover ...  |  read more...
$150.00
Biotechnology in Food Production Market Forecast 2014-2024
3/19/2014 | published by: Visiongain
... in food production that consider environmental and ecological issues, nutrient deficiencies and other more complex issues. The food system already looks different than it was 20 or 30 years ago: people are increasingly moving away ...  |  read more...
$2,788.00
Mass Spectrometry Market - by Technology (Tandem LC - MS/ Quadrupole/ ICP - MS/ Gas Chromatography - MS/ TOF - MS/ MALDI -TOF/ Fourier Transform - MS) & by Application (Pharmaceutical/ Biotechnology/ Environment/ Food & Beverages) - Global Trends & Foreca
3/14/2014 | published by: MarketsandMarkets
... & Beverages) - Global Trends & Forecast to 2018 Over the years, the mass spectrometry market—comprising of instruments, consumables, and services—has witnessed various technological advancements. These advancements have led to a growth in the number ...  |  read more...
$4,650.00
Baking Enzymes Market by Geography (North America, Europe, Asia-Pacific, Row), by Types (Carbohydrase, Protease, Lipase & Others) & by Application (Bread, Biscuits & Cookies, Cake & Pastry & Others) - Global Trends & Forecasts to 2019
3/13/2014 | published by: MarketsandMarkets
... to 2019 Enzymes, used as processing aids, in baking are the key differentiation factors for bakery improver manufacturers and a great source of product innovations and differentiation. The market for baking enzymes is expected to ...  |  read more...
$4,650.00
Industrial Enzymes Market by Types (Carbohydrase, Protease, Lipase), Applications (Food & Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), & Geography - Global Trends & Forecasts to 2018
3/13/2014 | published by: MarketsandMarkets
... enzymes, which can be broadly categorized as carbohydrases, proteases, lipases, and others.. Carbohydrase is the fastest growing segment of this market in terms of growth rate. Carbohydrases form the major class of enzymes that catalyzes ...  |  read more...
$4,650.00
Conference Documentation: Oncology imaging for drug development
3/12/2014 | published by: SMI Publishing, Ltd
... consider the current landscape of personalised imaging within the field of oncology. SMi's 10th annual event on oncology imaging will provide delegates with a comprehensive insight into current and future legislation and its impact on ...  |  read more...
$788.78
Animal Feed Additives Market by Types (Antibiotics, Vitamins, Antioxidants, Amino Acids,Feed enzymes), Livestock (Swine, Poultry, Cattle, Aquaculture, Others) & Geography - Trends & Forecasts (2011 - 2018)
3/12/2014 | published by: MarketsandMarkets
... substances which are not of natural origin and are added to prepared and stored feeds. Feed additives are gaining importance due to various functions such asgrowth promotion, controlling infectious diseases and enhancement of feed digestibility ...  |  read more...
$4,650.00
Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Protease, Lipase, Polymerases & Nucleases), Application (Pharmaceutical, Research & biotechnology, Diagnostic, Bio-Catalyst) & Geography - Global Trends & Forecasts to
3/12/2014 | published by: MarketsandMarkets
... natural proteins produced from micro organisms, plants and animals. An enzyme serves as catalysts for the chemical process that include the production of pharmaceuticals, diagnostics, research & biotechnology, and biocatalytic solutions. Enzymes increase reaction rates ...  |  read more...
$4,650.00
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014
3/12/2014 | published by: La Merie Publishing
... recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of March 2014. Marketed antibodies are attractive for companies to create next generation variants and ...  |  read more...
$1,523.00
  2    4  5  6  7  8  9  10  
 
Our Clients